Literature DB >> 22006020

The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells.

Wai-In Chan1, Rebecca L Hannah, Mark A Dawson, Clare Pridans, Donna Foster, Anagha Joshi, Berthold Göttgens, Jan M Van Deursen, Brian J P Huntly.   

Abstract

The transcriptional coactivator Cbp plays an important role in a wide range of cellular processes, including proliferation, differentiation, and apoptosis. Although studies have shown its requirement for hematopoietic stem cell (HSC) development, its role in adult HSC maintenance, as well as the cellular and molecular mechanisms underlying Cbp function, is not clear. Here, we demonstrate a gradual loss of phenotypic HSCs and differentiation defects following conditional ablation of Cbp during adult homeostasis. In addition, Cbp-deficient HSCs reconstituted hematopoiesis with lower efficiency than their wild-type counterparts, and this response was readily exhausted under replicative stress. This phenotype relates to an alteration in cellular fate decisions for HSCs, with Cbp loss leading to an increase in differentiation, quiescence, and apoptosis. Genome-wide analyses of Cbp occupancy and differential gene expression upon Cbp deletion identified HSC-specific genes regulated by Cbp, providing a molecular basis for the phenotype. Finally, Cbp binding significantly overlapped at genes combinatorially bound by 7 major hematopoietic transcriptional regulators, linking Cbp to a critical HSC transcriptional regulatory network. Our data demonstrate that Cbp plays a role in adult HSC homeostasis by maintaining the balance between different HSC fate decisions, and our findings identify a putative HSC-specific transcriptional network coordinated by Cbp.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006020      PMCID: PMC3233028          DOI: 10.1128/MCB.05830-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Hematopoietic progenitor/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo.

Authors:  Perpétua Pinto do O; Karin Richter; Leif Carlsson
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 2.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

Review 3.  Rubinstein-Taybi syndrome: clinical and molecular overview.

Authors:  Jeroen H Roelfsema; Dorien J M Peters
Journal:  Expert Rev Mol Med       Date:  2007-08-20       Impact factor: 5.600

4.  Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

Authors:  T P Yao; S P Oh; M Fuchs; N D Zhou; L E Ch'ng; D Newsome; R T Bronson; E Li; D M Livingston; R Eckner
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

5.  The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells.

Authors:  H Daniel Lacorazza; Takeshi Yamada; Yan Liu; Yasuhiko Miyata; Mariela Sivina; Juliana Nunes; Stephen D Nimer
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

Review 6.  Mechanisms of stem cell self-renewal.

Authors:  Shenghui He; Daisuke Nakada; Sean J Morrison
Journal:  Annu Rev Cell Dev Biol       Date:  2009       Impact factor: 13.827

7.  CREB is a critical regulator of normal hematopoiesis and leukemogenesis.

Authors:  Jerry C Cheng; Kentaro Kinjo; Dejah R Judelson; Jenny Chang; Winston S Wu; Ingrid Schmid; Deepa B Shankar; Noriyuki Kasahara; Renata Stripecke; Ravi Bhatia; Elliot M Landaw; Kathleen M Sakamoto
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

8.  FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

Authors:  Zuzana Tothova; Ramya Kollipara; Brian J Huntly; Benjamin H Lee; Diego H Castrillon; Dana E Cullen; Elizabeth P McDowell; Suzan Lazo-Kallanian; Ifor R Williams; Christopher Sears; Scott A Armstrong; Emmanuelle Passegué; Ronald A DePinho; D Gary Gilliland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

9.  Quantifying similarity between motifs.

Authors:  Shobhit Gupta; John A Stamatoyannopoulos; Timothy L Bailey; William Stafford Noble
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  CXCR4 is required for the quiescence of primitive hematopoietic cells.

Authors:  Yuchun Nie; Yoon-Chi Han; Yong-Rui Zou
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

View more
  23 in total

Review 1.  Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease.

Authors:  Isabel Beerman; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

2.  Aging-associated decrease in the histone acetyltransferase KAT6B is linked to altered hematopoietic stem cell differentiation.

Authors:  Eraj Shafiq Khokhar; Sneha Borikar; Elizabeth Eudy; Tim Stearns; Kira Young; Jennifer J Trowbridge
Journal:  Exp Hematol       Date:  2020-02-01       Impact factor: 3.084

3.  Loss of p300 accelerates MDS-associated leukemogenesis.

Authors:  G Cheng; F Liu; T Asai; F Lai; N Man; H Xu; S Chen; S Greenblatt; P-J Hamard; K Ando; X Chen; L Wang; C Martinez; M Tadi; L Wang; M Xu; F-C Yang; R Shiekhattar; S D Nimer
Journal:  Leukemia       Date:  2016-11-24       Impact factor: 11.528

4.  Isolation, characterization, and mesodermic differentiation of stem cells from adipose tissue of camel (Camelus dromedarius).

Authors:  Abdollah Mohammadi-Sangcheshmeh; Abbas Shafiee; Ehsan Seyedjafari; Peyman Dinarvand; Abdolhakim Toghdory; Iman Bagherizadeh; Karl Schellander; Mehmet Ulas Cinar; Masoud Soleimani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-01-09       Impact factor: 2.416

5.  C-reactive protein as an early marker of immune-related adverse events.

Authors:  Amir-Reza Abolhassani; Gerold Schuler; Michael Constantin Kirchberger; Lucie Heinzerling
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-06       Impact factor: 4.553

6.  The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

Authors:  G Giotopoulos; W-I Chan; S J Horton; D Ruau; P Gallipoli; A Fowler; C Crawley; E Papaemmanuil; P J Campbell; B Göttgens; J M Van Deursen; P A Cole; B J P Huntly
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 7.  STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells.

Authors:  Hein Schepers; Albertus T J Wierenga; Edo Vellenga; Jan Jacob Schuringa
Journal:  JAKSTAT       Date:  2012-01-01

8.  Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

Authors:  Sarah Picaud; Oleg Fedorov; Angeliki Thanasopoulou; Katharina Leonards; Katherine Jones; Julia Meier; Heidi Olzscha; Octovia Monteiro; Sarah Martin; Martin Philpott; Anthony Tumber; Panagis Filippakopoulos; Clarence Yapp; Christopher Wells; Ka Hing Che; Andrew Bannister; Samuel Robson; Umesh Kumar; Nigel Parr; Kevin Lee; Dave Lugo; Philip Jeffrey; Simon Taylor; Matteo L Vecellio; Chas Bountra; Paul E Brennan; Alison O'Mahony; Sharlene Velichko; Susanne Müller; Duncan Hay; Danette L Daniels; Marjeta Urh; Nicholas B La Thangue; Tony Kouzarides; Rab Prinjha; Jürg Schwaller; Stefan Knapp
Journal:  Cancer Res       Date:  2015-11-09       Impact factor: 12.701

9.  Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.

Authors:  Nirmala Mavila; David James; Sarah Utley; Nguyen Cu; Orly Coblens; Katrina Mak; C Bart Rountree; Michael Kahn; Kasper S Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention.

Authors:  Xudong Zhu; Zhiyang Chen; Weiyan Shen; Gang Huang; John M Sedivy; Hu Wang; Zhenyu Ju
Journal:  Signal Transduct Target Ther       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.